3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Anemia
6
Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Neoplasms, Plasma Cell
2
Mycosis Fungoides
2
Multiple Myeloma
2
Monoclonal Gammopathy of Undetermined Significance
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Prolymphocytic
2
Leukemia, Mast-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Large Granular Lymphocytic
2
Leukemia, Hairy Cell
2
Leukemia, Biphenotypic, Acute
2
Immunoglobulin Light-chain Amyloidosis
2
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
62
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
23
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
Nivolumab
11
rucaparib
10
durvalumab
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
Darbepoetin alfa
×
Clear all
No trials found.